EMBCEmbecta Corp.
Is it safe?
Caution warranted: heavy debt (BB) and big price swings.
Moderately leveraged. A rule of thumb on leverage, not a credit rating.
Large price swings, high volatility. Worst drawdown -93% · now 59% below its 52-week high.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can EMBC take a bad year?
Embecta Corp. carries $1.24B of net debt at 4.63× EBITDA: a heavy load to carry through a bad year.
Net debt · as at Q3 2026 · over four years of earnings before interest, tax and depreciation, heavy
- Net debt / EBITDA
- 4.63×
Net debt / EBITDA · 4.97× a year ago · the load is coming down
- Annualised volatility
- 72%
Annualised volatility · three times the market's own swing
- Worst drawdown on file
- −93%
Worst drawdown on file · −59% today
Details›
- Total debtQ3 2026
- $1.46B
- Cash and short-term investments
- $215M
- Net debt
- $1.24B
- EBITDA, trailing twelve months
- $268M
- Operating profit, trailing twelve months
- $224M
- Total debt / EBITDA
- 5.44×
- Annualised volatilitytwo years of daily moves
- 72%
- Worst drawdown on file
- −93%
- Below its 52-week high
- 59%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Medical Instruments & Supplies
Ranks #3 of 21 by RyuScore